The honest summary of pinealon research is that it is genuine, internally consistent, and concentrated almost entirely in one research tradition.

Pinealon is proposed to work by entering cells and influencing gene expression, possibly by binding directly to DNA.

There is no validated human dose for pinealon, because no regulator has approved it. That is the essential fact.

Pinealon is a three-amino-acid synthetic peptide developed in Russia and studied mainly for brain and cognitive effects.

Photo food logging is one of the lowest-effort ways to track eating, and that low effort is exactly why it works on a GLP-1.

Introduction Petrelintide and cagrilintide are the two front-runners in the amylin-analog race, and the comparison comes down to development strategy and trial outcomes rather…

Petrelintide does not have an approval date, and its timeline is best understood as a series of trial readouts stretching into the late 2020s.

Petrelintide is a long-acting amylin analog being developed by Zealand Pharma as a weekly injectable weight-loss drug.

Women over 40 are the target market for a huge amount of peptide marketing, and most of it overpromises.